This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $469,381 to The Leland Stanford Junior University to conduct research on "Engineering Cytotoxic Lymphocytes to Infiltrate Ovarian Cancer Tumors via Metabolite-Sensing Receptors". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical...
The federal Project Grant award of $4,232,760.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public, with a focus on innovative research to address critical health challenges. The grant will fund research over a 4-year period from June...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
The U.S. Defense Health Agency awarded a $3,128,801 Project Grant to The Leland Stanford Junior University under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 1, 2025 with a performance period through May 31, 2028, supports the development of "A BLOOD TEST TO MEASURE SLEEP DEPRIVATION AND CIRCADIAN TIME". This research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $131,655 to The Leland Stanford Junior University (Stanford University) to conduct research on identifying painful schwannomas using a sigma-1 receptor radioligand and PET/MRI imaging. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical capabilities in this area. The award period...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $370,866 formula grant to The Leland Stanford Junior University on April 1, 2025. The grant, titled "Uncovering Synthetically Lethal Genes in the Presence of Protein Folding Stress in Lung Cancer in vivo", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The 1-year grant period will run through...